Gelonghui October 30?China Resources Pharmaceutical (03320.HK) announced that in the first three quarters of 2023, 600422.SH achieved revenue of 5.611 billion yuan, down 9.4% from the same period last year; net profit belonging to shareholders of listed companies was 386 million yuan, up 3.58% from the same period last year; net profit belonging to shareholders of listed companies excluding non-recurring profits and losses was 311 million yuan, up 19.6% from the same period last year; and basic earnings per share was 0.51 yuan.
华润医药(03320.HK)：昆药集团前三季度净利润3.86亿元 同比增长3.58%
China Resources Pharmaceutical (03320.HK): Kunming Pharmaceutical Group's net profit of 386 million yuan in the first three quarters increased 3.58% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.